News & Insights

Blumberg Capital portfolio news, startup growth resources and industry insights

Home > News & Insights > SmithRx Raises $9 Million for Bespoke Drug Benefits Platform

SmithRx Raises $9 Million for Bespoke Drug Benefits Platform

Jan 11, 2018

Share

By Heather Mack

 

SmithRx, which has developed a platform for drug price negotiation and sales, has raised $9 million in Series A funding.

 

Founders Fund led the investment, with participation from Blumberg Capital, Box Group, NextGen Venture Partners and others. The funding is to be used for expansion efforts.

 

Read more.

Related Articles

post-image
The Six Ts for Startup Growth – 2024
post-image
Investing in FirmPilot, the AI Marketing Engine for Services SMBs
post-image
AI Law Firm Marketing Tool FirmPilot Secures $5M Series A
post-image
FirmPilot Closes $7M to Empower Law Firms and SMBs with AI-Driven Marketing
post-image
Permira to Acquire Majority Position in BioCatch at $1.3B Valuation
The 10 Most Promising Startups in 2024: FundGuard
post-image
Svexa and Zone7 merge operations to offer an end-to-end AI suite of performance tools
post-image
How to Navigate Startup Board Appointments & Meetings: Advice from Debora Tomlin & Juan Pujadas